Product
KN052
1 clinical trial
1 indication
Indication
Advanced Solid TumorClinical trial
A Phase Ia/Ib Clinical Study to Evaluate the Safety, Tolerability, Pharmacokinetics/Pharmacodynamics, and Antitumor Activity of KN052 in Chinese Subjects With Advanced Solid TumorsStatus: Terminated, Estimated PCD: 2023-11-14